C. diff vaccine moves closer to reality with launch of large Phase III trial
By
Tim Mullaney
May 19, 2014
A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes...
Acute, post-acute partnerships reduce C. diff about 50% in Washington state
By
Tim Mullaney
Mar 25, 2014
Hospitals and post-acute facilities in Washington state have cut their rate of Clostridium difficile infections in half since 2012 by partnering with each other in a robust infection control program, according...
C. diff spotlight: Vaccine trial and caregiver checklist
By
Tim Mullaney
Aug 07, 2013
Back in June, I declared medication to be the long-term care topic of the summer. But this week, a different topic has stolen the spotlight: Clostridium difficile.